This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd.. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Innovations in Liver Treatment by Quanwei Pan
Introduction
Quanwei Pan is a notable inventor based in Zhangzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of liver conditions. His innovative approach focuses on improving liver functioning through a specific compound.
Latest Patents
Quanwei Pan holds a patent for the pharmaceutical use of 2-(4-morpholinoaniline)-6-cyclohexyl aminopurine and/or its salts. This patent outlines a method for treating patients to enhance liver functioning. The drug, composed of the aforementioned compound, is administered in a manner and dosage effective for improving liver health. The compound has shown the ability to inhibit activated hepatic stellate cells from synthesizing and expressing collagens and other extracellular matrix proteins, which can help in reversing liver fibrosis. Additionally, it provides a method for preparing drugs aimed at treating various liver ailments, including hepatitis, liver cirrhosis, and liver cancer.
Career Highlights
Quanwei Pan is associated with Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd., where he continues to develop innovative solutions for liver health. His work has garnered attention for its potential impact on treating serious liver conditions.
Collaborations
He collaborates with notable colleagues, including Ka Ho Kenneth Lee and Ruohan Chen, to further advance research in this critical area of medicine.
Conclusion
Quanwei Pan's contributions to liver treatment through his innovative patent highlight the importance of research in pharmaceuticals. His work not only addresses significant health issues but also paves the way for future advancements in liver therapy.